Details for New Drug Application (NDA): 090560
✉ Email this page to a colleague
NDA 090560 describes NAFCILLIN SODIUM, which is a drug marketed by Antibiotice, Apothecon, Eugia Pharma Speclts, Fresenius, Istituto Bio Ita Spa, Onesource Specialty, Sagent Pharms, Sandoz, and Watson Labs Inc, and is included in fifteen NDAs. It is available from eleven suppliers. Additional details are available on the NAFCILLIN SODIUM profile page.
The generic ingredient in NAFCILLIN SODIUM is nafcillin sodium. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.
The generic ingredient in NAFCILLIN SODIUM is nafcillin sodium. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.
Summary for 090560
| Tradename: | NAFCILLIN SODIUM |
| Applicant: | Antibiotice |
| Ingredient: | nafcillin sodium |
| Patents: | 0 |
Suppliers and Packaging for NDA: 090560
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| NAFCILLIN SODIUM | nafcillin sodium | INJECTABLE;INJECTION | 090560 | ANDA | Heritage Pharmaceuticals Inc. d/b/a/ Avet Pharmaceuticals Inc. | 23155-906 | 23155-906-41 | 10 VIAL in 1 CARTON (23155-906-41) / 4 mL in 1 VIAL |
| NAFCILLIN SODIUM | nafcillin sodium | INJECTABLE;INJECTION | 090560 | ANDA | Heritage Pharmaceuticals Inc. d/b/a/ Avet Pharmaceuticals Inc. | 23155-907 | 23155-907-41 | 10 VIAL in 1 CARTON (23155-907-41) / 8 mL in 1 VIAL |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1GM BASE/VIAL | ||||
| Approval Date: | Oct 3, 2011 | TE: | AP | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Oct 3, 2011 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
